Exciting Research Breakthrough: CCL7 Antagonist for Wound Healing!

We’re thrilled to announce that Dr. Ting-Ting Chang and her research team have published a groundbreaking study in Science Translational Medicine (PMID: 39231238).

Their discovery of a CCL7 antagonist that promotes wound healing has been awarded patents for its innovative therapeutic potential. This breakthrough opens up a promising new strategy for microvascular repair and chronic wound healing in diabetic patients, offering new hope to those suffering from diabetes-related vascular complications.

👏 Huge congratulations to Dr. Chang and her team on this remarkable achievement in translational medicine!